Biotech Values

[RockRat]

When are we going to know for sure the Teva overhang is gone, Thomas? Hmmmm? I think there is a good chance that if t-enox is not approved by the middle of next year, Teva and its cast of supporting analysts will finally have spent their credibility, and MNTA shares could ramp pretty hard with that change in sentiment. I think the Markman decision, late as it is, will come before then. Obviously, a positive outcome on that will help the MC.

Bottom line, I think MNTA's MC has essentially no chance of whatsoever of improving for about 2 months. I would love to be wrong.

Regards, RockRat